The 3D printed biocompatible FibreTuff PAPC advanced Nylon composition has a cellular structure with a porous and non porous surface. The company is now a service bureau for providing solutions with bone like performance and limitations to continuously absorb liquids and gases.
3D Printing FibreTuff PAPC filament and or powders as of November 1, 2024 MSRP will not be sold without purchasing a technology license. For more information please contact robert@fibretuff.us
The 3D printing of FibreTuff PAPC biocompatible filaments can be printed with very tight tolerances. In addition, porosity is naturally printed. A bone ring can be identified requiring 2500 HU
The 3D printing FibreTuff biocompatible filaments produced a skull flap. The PAPC is cut at high speeds - 15,000 RPM and the cutter doesn't melt the composition. Further, the novel composition doesn't have heavy radiopaque minerals or additives to promote osteo conductivity. The FibreTuff is biocompatible, absorbent and non resorbable for the most advanced solution for point of care.
An alternative to Nylon 12 powder for an improved experience for 3D printing filament or powders for the medical professional. email robert@fibretuff.us for more information and purchase.
3D printing FibreTuff biocompatible filaments for capacitive touch applications. See 3D Printer nScrypt Utilizes FibreTuff's PEEK Alternative PAPC 3D Printing Filaments
All FibreTuff biocompatible materials for 3D Printed parts are hydrophilic. These bone models are exposed to water to absorb moisture to increase flexibility and impact. Real bone will react similar when exposed to body fluids.
FibreTuff medical grade filament requires a heated build plate or adhesive for 3D Printing. Utilizing EZ-STIK GeckoTek build plate with 225C nozzle temperature and heated bed at 95C with PAPC II is preferred. https://www.geckotek.co/collections/build-plates/products/ez-stik-hot-build-plate
Bart van As of Ultimaker describes FibreTuff "bone like" filament for 3D printing. Robert Joyce nominated for 2021 Innovator.
This website uses cookies. By continuing to use this site you accept our use of cookies.